INDBInternet News Database 2.5 Updated 1 min ago · 397 sources Show or hide images Light or dark

'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment

Save Like Comments Compare coverage
Image from Medpagetoday

Summary

(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from an early...

Description from Medpagetoday.

Who is covering this

  1. Medpagetoday Center Factuality: Mostly factual US
    'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment

    (MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from an early...

Comments

Comments need JavaScript.